Gary J. Grazioso currently serves as CEO of eMed Screen, LLC. Responsible for the P&L management, execution, and expansion of eMed digital health service solutions allowing more accessible and affordable ways for consumers and key commercial channels including large employers, health plan payors, providers, and government agencies. Using the mission as a guiding principle as CEO of eMed Screen LLC with a focus on breaking new ground in affordability, access, security, and reliability utilizing eMed’s secure exam proctoring and identification verification processes to deliver program compliance and adherence.Prior to joining eMed Gary has spent more than 30 years in life sciences with companies like Dun and Bradstreet, Johnson and Johnson, Organon Pharmaceuticals, Managed Health Care Associates. Most recently he spent 12 years at Quest Diagnostics where he held several senior leadership roles focused on commercial market expansion and accelerated growth initiatives. Gary’s experience in assessing market dynamics and developing commercial execution strategies to mobilize teams has led to a proven successful track record.